Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment
Year: 2002
Type: review
Abstract: A peer reviewer notes that use of soluble CD23 levels in the UK is rare and that much greater emphasis
Source: Health Technology Assessment
DOI: 10.3310/hta6020
Institution: University of Birmingham
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Awards: G5358830265, G8453750176
OpenAlex ID: W1993553202
